Purchases and Sales Made in Q3 2023 in Nls Pharmaceutics Ltd. (NLSP)
This table provides information about the institutional ownership of Nls Pharmaceutics Ltd. (NLSP) during Q3 2023. The information is specifically focused on institutions that hold shares of NLS Pharmaceutics Ltd..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
56.5KNew |
$39.6K - $80.3K
|
56.5K
$107K
|
|
|
Nov 14, 2023
Q3 2023
|
J. Goldman & CO LP
New York, NY |
BUY
|
- |
50.3K+ 24.6% |
$35.2K - $71.4K
|
255K
$481K
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-33.6K- 61.43% |
$23.5K - $47.7K
|
21.1K
$39.9K
|
|
|
Nov 14, 2023
Q3 2023
|
Affinity Asset Advisors, LLC
New York, NY |
SELL
|
- |
-200K- 49.89% |
$140K - $283K
|
200K
$379K
|